Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Phys Clinical Casesdermatological

Phys Clinical Cases · dermatological

Genodermatoses with Systemic Significance — DCE Clinical Case

DCE long-case and short-case station for Genodermatoses with Systemic Significance.

On this page & tools

Target exams

FRACP DCEMRCP PACES

Target exams

FRACP DCEMRCP PACES
Prompt
DCE long-case and short-case station for Genodermatoses with Systemic Significance.

Genodermatoses with Systemic Significance — Clinical Case

DCE Long Case

Patient brief

Patient: A middle-aged or older adult with multimorbidity and a presentation centred on Genodermatoses with Systemic Significance. [1]

Presenting complaint: Subacute or acute symptoms referable to Genodermatoses with Systemic Significance, with enough detail to force prioritisation. [1] [2]

Past history: Common cardiometabolic and organ comorbidities that interact with the plan. [2]

Medications: A polypharmacy list that includes at least one interaction or dosing issue. [2]

Examination: Key positives and critical negatives for dangerous differentials. [1]

Investigations: A small set of results that change management. [1] [2]

Tasks

  1. Present a prioritised problem list. [1]
  2. Defend investigations and immediate therapy. [1] [2]
  3. Provide safety-net and follow-up advice. [2]

Model discussion points

  • Working diagnosis and acuity. [1]
  • Differentials and discriminators. [2]
  • Treatment sequence and monitoring. [1] [2] [3]
  • Multimorbidity and communication. [2]

Short case

Focused examination or counselling station linked to Genodermatoses with Systemic Significance, with one interpretation task and one shared-decision point. [1] [2]

References

  1. [1]Wagner RN, Piñón Hofbauer J, Wally V, Kofler B, et al. Epigenetic and metabolic regulation of epidermal homeostasis Exp Dermatol, 2021.PMID 33600038
  2. [2]Youssefian L, Vahidnezhad H, Touati A, Ziaee V, et al. The genetic basis of hyaline fibromatosis syndrome in patients from a consanguineous background: a case series BMC Med Genet, 2018.PMID 29801470
  3. [3]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
  4. [4]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
  5. [5]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906
  6. [6]Aw Hashi MO, Derie AM, Ahmed SI Lamellar Ichthyosis in a Resource-Limited Setting: A Somaliland Case Report Int Med Case Rep J, 2026.PMID 41940243
  7. [7]Boitez P, Farges D, Descamps M, Bournazel V, et al. The first year of treatment with selumetinib for NF1-related plexiform neurofibroma is medically challenging in real-life settings Ann Dermatol Venereol, 2026.PMID 41411884
  8. [8]Rossignol J, Bouillet L, Bulai-Livideanu C, Barete S, et al. Diagnosis, management and the burden of symptoms of mastocytosis from the physician's perspective: A nationwide study Br J Haematol, 2025.PMID 40930805